If you're over 18 and living with #Type2Diabetes , you could take part in a home-based insulin trial in part of the project @trialsathome 🏘️ who are testing remote studies as a way to involve more people in #research .📣 #TrialTuesday IDFEurope / Diabetes Ken Tait

📣I am looking for around 30 participants to take part in my research project. If you have #T1DM or #T2DM and you would like to receive a self-compassion intervention, please sign up at: cccusocialsciences.az1.qualtrics.com/jfe/form/SV_aW… #GBDoc #ScotDoc #NIDoc #DClinPsy #DiabetesResearch #TrialTuesday

For #trialtuesday , #CCTI_DFCI presents new trial 23-600 led by Filipa Lynce, MD, FASCO. IDE161, a PARG inhibitor, targets HRD and BRCA mutations in ER+ breast, endometrial, colorectal, and head and neck with these mutations. Different from PARPi. Dana-Farber
Visit: forms.office.com/r/kM7e6JVxre

Today’s #trialtuesday is led by Alok Tewari of Dana-Farber Lank Center for Genitourinary Oncology. #CCTI_DFCI presents Trial 23-643: USP1 inhibitor for BRCA 1/2, PALB2, RAD51C/D mutated or HSD positive solid tumors. Now in dose escalation. @DanaFarber Dana-Farber News
Visit: forms.office.com/r/kM7e6JVxre

For #TrialTuesday , .Thomas Hope UC San Francisco .Sukhmani (Suki) Padda MD Cedars-Sinai lead a trial that studies the effect of everolimus vesus 177Lu-dotatate in patients with bronchial #neuroendocrine tumors - Alliance for Clinical Trials in Oncology A021901. Visit bit.ly/Alliance-A0219… #brochialcancer #NCI #NCTN .ECOG-ACRIN Cancer Research Group

#trialtuesday is Trial 23-044: STX-478 mutant-selective, PI3Kα small molecule inhibitor, highly selective for kinase and/or helical domain mutations in breast, gynecological, head and neck, and other solid tumors #CCTI_DFCI Dana-Farber Antonio Giordano, MD PhD
Visit: forms.office.com/r/kM7e6JVxre

Thanks Pete for always having a welcoming, feel, and a hot meal after a long day in trial! Love this place love this team! @stpetes_dancingmarlin @pazotos #Tuesday Trial #Trial Tuesday #Tuesday #Trial #BeGreat #GetAfterIt #lfg

For #TrialTuesday , . judy garber Dana-Farber leads Alliance for Clinical Trials in Oncology A211801 (BRCA-P Study) to compare denosumab to placebo for the prevention of #breastcancer in women with a BRCA1 germline mutation. Visit bit.ly/Alliance-A2118… #NCI #NCORP #BCsm .Sisters Network Inc. .NBCF .BreastCancerTrials.org

#TrialTuesday Dark Surfer now in long Sleeve and Short Sleeve silverreef.co.uk #tshirt #adventure #surftrip

#TrialTuesday : STELLAR-303 is a phase III #clinicaltrial evaluating the novel tyrosine kinase inhibitor XL092 (zanzalintinib) + atezolizumab versus regorafenib in patients with metastatic #colorectalcancer ➡️ jeffersonhealth.org/clinical-speci…
#ColorectalCancerAwarenessMonth Daniel Lin, MD

#TrialTuesday : The PERIO-02 clinical trial is evaluating our #immunotherapy platform in patients living with #hepatocellularcarcinoma and #intrahepaticcholangiocarcinoma . Visit our trial website to learn more about enrollment and eligibility: perio2trial.com

#TrialTuesday Diabetes UK Research
If you would like to participate, I am still recruiting adults with Type 1 or 2 Diabetes to take part in a self-compassion intervention.

Link to sign up: cccusocialsciences.az1.qualtrics.com/jfe/form/SV_aW…

#GBDoc DiabetesChat Diabetes UK Professionals

Just like a well-crafted case, let's approach this Tuesday with precision and finesse.

Ready to strengthen your legal practice? Contact us today at (877) 631 – 9711.

#InstaAnswer #TrialTuesday #CustomerService

We know your time is valuable, and every call is crucial. That's why Insta Answer is here to ensure you never miss an opportunity to represent justice!

Contact us at (877) 631 – 9711 and let's make your legal practice a winning one!

#InstaAnswer #TrialTuesday #CustomerService

📣There's still time for you to take part in this study about long-term conditions like #diabetes . Follow this link to find out more👉🏾qualtrics.kcl.ac.uk/jfe/form/SV_8c… #TrialTuesday

Only canola, corn, an intercropping trial, and a few oat and triticale plots left for #harvest23 . We're about 85-90% complete! Bring on the sunshine!

#TrialTuesday #AgResearch #plots #ABAg #GRO

For #TrialTuesday , .Tian Zhang, MD, MHS UTSW Simmons Cancer Center leads Alliance for Clinical Trials in Oncology A031704/PDIGREE to see how well nivolumab & ipilimumab, followed by nivolumab vs cabozantinib & nivolumab, work in treating pts w/untreated advanced #renalcellcancer . Visit bit.ly/AllianceA031704 #NCI #NCTN

‼️There's still time for you to take part in this research about #diabetes and feeling in your feet 👣

#TrialTuesday

Peter Navarro, second ex-Trump aide to be prosecuted for contempt of Congress, faces trial Tuesday

#PeterNavarro
#ExTrumpAide
#ContemptOfCongress
#TrialTuesday

Former White House trade adviser Peter Navarro goes on trial Tuesday as the second ex-aide to former Presi

#TrialTuesday : Dr. Maria Werner-Wasik is leading a trial studying whether adding the immunotherapy drug atezolizumab to the usual radiation therapy works better in treating patients with early-stage non-small cell lung cancer. jeffersonhealth.org/clinical-speci…
#LungCancerAwareness #RadOnc